Table 1 Study outcomes measurement for both groups of participant
Outcome measurement | Method | Week 1 Baseline (T1) | Week 12 (T2) | Week 24 (T3) |
|---|---|---|---|---|
Primary outcomes | ||||
Psychology health | DASS-21 | x | x | x |
QoL | FACT-B version 4 questionnaire | x | x | x |
Immune cell functions | Isolation of peripheral blood mononuclear cells | x | x | x |
Secondary outcomes | ||||
Daily step count/Average activity volume assessment | Step count tracker | x | x | x |
Adherence in pedometer usage | Step count tracker wearing time with data capture (daily hours and the number of wearing days) | x | x | |
Exercise self-regulation; | BREQ2 | x | x | x |
Exercise barrier and task self-efficacy | Exercise barrier and task self-efficacy rating scale | x | x | x |